Table 1.
Characteristics of Amazonian indigenous Peruvians with confirmed COVID-19 during 2020
| Characteristic | N = 19 018 |
|---|---|
| Female, n (%) | 10 897 (57.3%) |
| Age, Median (IQR) | 34 (22, 48) |
| Age group, n (%) | |
| Early childhood | 803 (4.2%) |
| Childhood | 1015 (5.3%) |
| Adolescence | 1356 (7.1%) |
| Young adults | 4350 (22.9%) |
| Middle adults | 9308 (48.9%) |
| Older adults | 2186 (11.5%) |
| Health worker, n (%) | 322 (1.7%) |
| Number of symptoms, n (%) | |
| 0 | 550 (2.9%) |
| 1–2 | 4993 (26.3%) |
| 3–4 | 7532 (39.6%) |
| >4 | 5943 (31.2%) |
| Symptoms, n (%) | |
| Headache | 12 555 (66.0%) |
| Cough | 11 617 (61.1%) |
| General malaise | 9822 (51.6%) |
| Sore throat | 8851 (46.5%) |
| Fever | 8424 (44.3%) |
| Nasal congestion | 4960 (26.1%) |
| Muscle pain | 4093 (21.5%) |
| Respiratory distress | 3026 (15.9%) |
| Diarrhea | 2948 (15.5%) |
| Chest pain | 2481 (13.0%) |
| Nausea | 1588 (8.3%) |
| Joint pain | 1451 (7.6%) |
| Abdominal pain | 1177 (6.2%) |
| Irritability | 456 (2.4%) |
| Risk conditions, n (%) | |
| 0 | 18 278 (96.1%) |
| 1 | 702 (3.7%) |
| 2 | 38 (0.2%) |
| Risk conditions, n (%) | 740 (3.9%) |
| Pregnancy | 351 (1.8%) |
| Cardiovascular disease | 149 (0.8%) |
| Diabetes | 117 (0.6%) |
| Obesity | 57 (0.3%) |
| Postpartum | 14 (0.1%) |
| Asthma | 15 (0.1%) |
| Chronic neurological disease | 16 (0.1%) |
| Renal disease | 11 (0.1%) |
| Liver disease | 15 (0.1%) |
| Immunodeficiency | 21 (0.1%) |
| Chronic lung disease | 9 (0.0%) |
| Cancer | 3 (0.0%) |
| Hospitalized, n (%) | 193 (1.0%) |
| Mechanical ventilation, n (%) | 16 (0.1%) |
IQR = interquartile range